These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 9734683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E, Ahlquist D, Ullrich S, Gross WL.
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
    Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, von dem Borne AE, Kallenberg CG, Goldschmeding R.
    Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
    [Abstract] [Full Text] [Related]

  • 7. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
    van der Geld YM, Tool AT, Videler J, de Haas M, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG, Roos D.
    Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
    Specks U, Wiegert EM, Homburger HA.
    Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
    Baslund B, Petersen J, Permin H, Wiik A, Wieslander J.
    J Immunol Methods; 1994 Oct 14; 175(2):215-25. PubMed ID: 7930650
    [Abstract] [Full Text] [Related]

  • 15. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
    van de Wiel BA, Dolman KM, van der Meer-Gerritsen CH, Hack CE, von dem Borne AE, Goldschmeding R.
    Clin Exp Immunol; 1992 Dec 14; 90(3):409-14. PubMed ID: 1458677
    [Abstract] [Full Text] [Related]

  • 16. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
    Van Der Geld YM, Simpelaar A, Van Der Zee R, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG.
    Kidney Int; 2001 Jan 14; 59(1):147-59. PubMed ID: 11135067
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG.
    J Autoimmun; 2008 Jan 14; 30(1-2):29-36. PubMed ID: 18162369
    [Abstract] [Full Text] [Related]

  • 18. Correlation between the levels of circulating adhesion molecules and PR3-ANCA in Wegener's granulomatosis.
    Takizawa M, Maguchi S, Nakamaru Y, Miyatake Y, Fukuda S, Inuyama Y.
    Auris Nasus Larynx; 2001 May 14; 28 Suppl():S59-62. PubMed ID: 11683345
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.